Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer
by Society of Nuclear MedicineA radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detecte
Updated on: April 06,2024
0
Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer
by Society of Nuclear MedicineA radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detecte
Updated on:April 06,2024
0
